Terms of Reference

Inquiry into allergies and anaphylaxis

The House of Representatives Standing Committee on Health, Aged Care and Sport will inquire into and report on:

  1. The potential and known causes, prevalence, impacts and costs of anaphylaxis in Australia;
  2. The adequacy of food and drug safety process and food and drug allergy management, auditing and compliance (including food allergen labelling by manufacturers and food service providers);
  3. The adequacy and consistency of professional education, training, management/treatment standards and patient record systems for allergy and anaphylaxis;
  4. Access to and cost of services, including diagnosis, testing, management, treatment and support;
  5. Developments in research into allergy and anaphylaxis including prevention, causes, treatment and emerging treatments (such as oral immunotherapy);
  6. Unscientific diagnosis and treatments being recommended and used by some consumers; and
  7. The impact of unnecessary drug avoidance due to unconfirmed drug allergies and its management, such drug allergy ‘de-labelling’.

Committee Secretariat contact:

PO Box 6021
Parliament House
Canberra ACT 2600

Phone: +61 2 6277 4145

About this inquiry

Following a referral on 27 August 2019 from the Minister for Health, The Hon Greg Hunt MP, the Committee will inquire into and report on allergies and anaphylaxis.

Past Public Hearings

18 Feb 2020: Brisbane
17 Feb 2020: Adelaide
13 Feb 2020: Canberra


Inquiry Status

Submissions Closed


If you require any special arrangements to enable you to participate in the Committee's inquiry, please contact the Committee Secretariat.

Further information regarding accessibility can be found at www.aph.gov.au/Help/Accessibility